Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oté Pharma Sol is a Netherlands-based healthcare company specializing in the development and manufacturing of contact lens care products and eye care solutions. Founded in 1979, the company offers a comprehensive portfolio including all-in-one solutions, peroxide systems, and lubricating eye drops for dry eye relief. Oté operates as both a brand owner and a contract manufacturer (CMO), providing private label services to global partners in the optical industry. In 2019, the company was acquired by the Urgo Group, integrating into their healthcare division to expand its international reach in the ophthalmology market. The company maintains high-quality manufacturing standards for medical devices and ophthalmic liquids.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oté Pharma.